Mellian, Luminado T.
HRN: 21-27-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/20/2022
04/27/2022
IV
500mg
Q8H
Incarcerated Inguinal Hernia, Left
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes